Stritch School of Medicine

The Caris Precision Oncology Alliance Welcomes Loyola University Chicago's Stritch School of Medicine

Retrieved on: 
Tuesday, September 12, 2023
Database, FACP, Cancer, Intelligence, MBA, Loyola University, Radiation therapy, POA, Stritch School of Medicine, Patient, Physician, Machine learning, AI, Gibbs Cancer Center & Research Institute, Loyola University Chicago, Dentistry, Medical imaging, Medicine

IRVING, Texas, Sept. 12, 2023 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, announced today that Loyola University Chicago's Stritch School of Medicine has joined the Caris Precision Oncology Alliance™ (POA).

Key Points: 
  • IRVING, Texas, Sept. 12, 2023 /PRNewswire/ -- Caris Life Sciences ®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, announced today that Loyola University Chicago's Stritch School of Medicine has joined the Caris Precision Oncology Alliance™ (POA).
  • The Caris Precision Oncology Alliance welcomes Loyola University Chicago's Stritch School of Medicine.
  • "We're happy to welcome Loyola University and the Cardinal Bernadin Cancer Center into the growing Caris Precision Oncology Alliance network," said Chadi Nabhan , M.D., MBA, FACP, Chairman of the POA.
  • The Caris Precision Oncology Alliance includes 89 cancer centers, academic institutions, research consortia and healthcare systems.

The Inner Circle Acknowledges, Julie Lynn Fitzgerald, MD, FAAP as a Most Trusted Healthcare Professional in the Medical Field

Retrieved on: 
Friday, April 7, 2023
Bachelor, Society, University, Pediatrics, Bed, Elective surgery, Society of Critical Care Medicine, Critical Care Medicine (journal), Burn center, Nephrology, Pediatrics (journal), Cancer, Disease, American Academy, Loyola University Medical Center, Multimedia, Mentorship, Loyola University, Disorder, Inner circle, Villanova University, FAAP, Association of American Medical Colleges, Stritch School of Medicine, Patient, Ophthalmology, Gambat Liver Transplant Center, Cardiology, LUMC, Family, Medical specialty, Injury, Nursing, Dentistry, MD, Medicine

BURR RIDGE, lll., April 7, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Julie Lynn Fitzgerald, MD, FAAP, is acknowledged as a Most Trusted Healthcare Professional in the Medical Field.

Key Points: 
  • BURR RIDGE, lll., April 7, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Julie Lynn Fitzgerald, MD, FAAP, is acknowledged as a Most Trusted Healthcare Professional in the Medical Field.
  • Dr. Fitzgerald earned a Bachelor's degree at Villanova University and completed her medical degree (M.D.)
  • Dr. Fitzgerald is a practicing pediatrician and critical care physician who cares for young patients at Loyola University Medical Center (LUMC) in Maywood, IL.
  • According to Dr. Fitzgerald, pediatricians typically work with infants, children, teenagers, and young adults up to the age of 21.

Amrish T. Patel, MD, is recognized by Continental Who's Who

Retrieved on: 
Thursday, January 12, 2023
Infection, Fracture, Mentorship, Continental, University, Orthopedic surgery, Elbow, Neoplasm, Human, Stritch School of Medicine, Wrist, American Society for Surgery of the Hand, Birth, Trauma, Forearm, Diagnosis, Degenerative disease, Rice University, Loyola University Medical Center, Patient, Finger, Loyola University, American Academy, Society, Chicago (franchise), Physician, Dentistry, MD, Medicine, Hand

MARIETTA, Ga., Jan. 12, 2023 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an orthopedic surgeon specializing in hand and upper extremity surgery.

Key Points: 
  • MARIETTA, Ga., Jan. 12, 2023 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an orthopedic surgeon specializing in hand and upper extremity surgery.
  • He moved to Houston and earned his Bachelor of Science degree in mechanical engineering from Rice University.
  • Dr. Patel is a member of the American Academy of Orthopedic Surgery and the American Society for Surgery of the Hand.
  • The doctor would like to acknowledge his mentors: Daniel Mass, MD, and the owner of this practice, Viral Kumar Patel, MD.

Frontier Medicines Advances First Development Candidate, FMC-376, a Uniquely Differentiated Inhibitor of Both Active and Inactive KRASG12C, into IND-Enabling Studies

Retrieved on: 
Thursday, January 5, 2023
Precision medicine, Stritch School of Medicine, Druggability, NCI, Trastuzumab, Rituximab, SAN, Loyola University, Patient, Frontier, AI, Safety, GTP, Internal medicine, IND, Erlotinib, National Cancer Institute, Proteome, Cedars-Sinai Medical Center, Pharmaceutical industry, Genentech, Development

SOUTH SAN FRANCISCO, Calif. and BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company advancing transformative drugs against historically undruggable disease-causing targets, announced the selection of its first development candidate, FMC-376, an oral, covalent small-molecule inhibitor that selectively targets both active (GTP-bound) and inactive (GDP-bound) conformations of KRASG12C. In preclinical studies, FMC-376 retains potency in the context of receptor tyrosine kinase activation, which is likely a major mechanism of non-response and resistance to prior generation inhibitors that only target inactive (GDP-bound) KRASG12C. Preclinical data for FMC-376 supports a potential best-in-class profile for safety and efficacy, with the promise of first-line treatment in both monotherapy and combination use. IND filing for FMC-376 is planned for this year.

Key Points: 
  • Preclinical data for FMC-376 supports a potential best-in-class profile for safety and efficacy, with the promise of first-line treatment in both monotherapy and combination use.
  • Dr. Klein has more than 20 years of oncology drug development experience across industry and academia.
  • At Genentech, Dr. Klein led development and medical affairs for a portfolio of oncology programs including trastuzumab (Herceptin), rituximab (Rituxan), pertuzumab (Perjeta) and erlotinib (Tarceva).
  • She trained in internal medicine at Cedars-Sinai Medical Center and Oncology at the NCI, serving as chief oncology fellow during that time.

Kathryn Podgorny, MD, is being recognized by Continental Who's Who

Retrieved on: 
Thursday, December 29, 2022
University of North Carolina, ABA, Hobby, American Board of Anesthesiology, Patient, Pulse, Family, Overalls, Continental, Travel, PARK, Health, Skiing, University, Stritch School of Medicine, Respiration, Main Street, Saint Joseph, Medical degree, Peace Corps, Medicine, Running, MD, Peace, HIV, Beauty, Elective surgery, Blood pressure, Multimedia, Plastic surgery, Vital signs, IV, College, IQ, Master, American Board of Commissioners for Foreign Missions, Temperature, Yoga, Dentistry, Medical device, Anesthesiology, Day spa

PARK RIDGE, Ill., Dec. 29, 2022 /PRNewswire/ -- Kathryn Podgorny, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional and for her work at Uptown Med Spa.

Key Points: 
  • PARK RIDGE, Ill., Dec. 29, 2022 /PRNewswire/ -- Kathryn Podgorny, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional and for her work at Uptown Med Spa.
  • The doctor then earned a Medical Degree and Anesthesiology residency completion at Loyola University Stritch School of Medicine.
  • She is board certified in Anesthesiology by the American Board of Anesthesiology (ABA) and credentialed in Aesthetic Medicine.
  • Dr. Podgorny opened her own business, Uptown Med Spa, in January 2021 to offer high-quality aesthetic treatments to her patients.

Julie Lynn Fitzgerald, MD, FAAP is recognized by Continental Who's Who

Retrieved on: 
Thursday, November 3, 2022
Pediatrics, Disorder, Elective surgery, III, Loyola University, FAAP, Cardiology, Multimedia, Burn center, American Academy, Loyola University Medical Center, Association of American Medical Colleges, Stritch School of Medicine, Critical Care Medicine (journal), Continental, Society of Critical Care Medicine, Patient, University, Pediatrics (journal), Family, Mentorship, Villanova University, Injury, LUMC, Bachelor, Ophthalmology, Bed, Disease, Society, Association, Nephrology, Cancer, Medical specialty, Medicine, MD

BURR RIDGE, III., Nov. 3, 2022 /PRNewswire/ -- Julie Lynn Fitzgerald, MD, FAAP, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical Field, acknowledging her excellence with Loyola University Medical Center.

Key Points: 
  • BURR RIDGE, III., Nov. 3, 2022 /PRNewswire/ -- Julie Lynn Fitzgerald, MD, FAAP, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical Field, acknowledging her excellence with Loyola University Medical Center.
  • Dr. Fitzgerald is a practicing pediatrician and critical care physician who cares for young patients at Loyola University Medical Center (LUMC) in Maywood, IL.
  • As a pediatrician and critical care physician, she diagnoses and treats life-threatening infections, injuries, diseases, and other disorders in children.
  • According to Dr. Fitzgerald, pediatricians typically work with infants, children, teenagers, and young adults up to the age of 21.

The Fenway Institute Offers Recommendations for Improving Human Papillomavirus Vaccination Rates in US

Retrieved on: 
Sunday, October 2, 2022
Adult, Wart, ACIP, Health, Safety, Sex, LGBT, Anal cancer, COVID-19, Woman, STI, Vaccination, HIV, Population, Life, Loyola University Chicago, Loyola University, Stritch School of Medicine, Patient, White, Fenway Health, Fenway Park, Advisory Committee, Human papillomavirus infection, Vaccine, Head, Federally Qualified Health Center, Gender identity, HPV, Stockholm Environment Institute US Center, Research, Ageing, Parent, PDF, Human, Awareness, Man, Neck, Policy

BOSTON, October 02, 2022  /PRNewswire-PRWeb/ -- A policy brief published by The Fenway Institute at Fenway Health offers recommendations to health professionals and policy makers on how to improve Human Papillomavirus (HPV) vaccination rates in the U.S. HPV is the most common sexually transmitted infection (STI) in the world. Approximately 79 million Americans, most in their teens and early 20s, are infected with HPV despite the widespread availability of a safe and effective vaccine since 2006.

Key Points: 
  • But vaccination rates remain far below optimal rates of coverage, especially among male-identifying individuals.
  • There are other disparities in vaccination rates across populations of varying sexual and gender identities, as well as race and ethnicity.
  • The policy brief, titled "Improving Human Papillomavirus vaccination rates in the U.S.: Recommendations for health professionals and policy makers," addresses barriers to HPV vaccination, including the politicization of vaccines, sex and gender-based stigma, medical mistrust, misinformation, and insufficient provider recommendation.
  • "Improving Human Papillomavirus vaccination rates in the U.S.: Recommendations for health professionals and policy makers," is available for download as a PDF here .

Prodeon Medical, Inc., Announces Randomization in the Expander-2 Pivotal Clinical Trial Evaluating the Company's Investigational Treatment for Lower Urinary Tract Symptoms Associated to Benign Prostatic Hyperplasia

Retrieved on: 
Monday, September 26, 2022
Urinary catheterization, Safety, Journal, Research, Anesthesia, Compliance, Loyola University, Patient, Virginia Tech Carilion School of Medicine and Research Institute, Technology, NCT, Prostate, Control, Kidney, BPH, Prostate cancer, Time, Common, Bleeding, Sale, Coronavirus Scientific Advisory Board (Turkey), Man, Depression, Burn, Dizziness, Time-invariant system, Prostatic urethral lift, Woman, LUTS, Efficacy, Stritch School of Medicine, CEO, Sexual dysfunction, Cystoscopy, Incontinence, Department, Headache, Quality of life, Dementia, PURE, The Indwelling, Pharmaceutical industry, Medical imaging, TURP, Urology

BPH is a condition where the prostatic tissue grows over time and obstructs the urethral lumen, leading to LUTS.

Key Points: 
  • BPH is a condition where the prostatic tissue grows over time and obstructs the urethral lumen, leading to LUTS.
  • The interim results of the EXPANDER-1 trial were recently published in the Journal of Prostate Cancer and Prostate Diseases [The EXPANDER-1 trial: introduction of the novel Urocross Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)].
  • Within the Expander-2 Trial, the Urocross Expander System and Retrieval Sheath will be used in a newly developed procedure called PURE (Prostatic Urethral REshaping) to relieve symptoms associated with BPH.
  • The Urocross Expander System and Urocross Retrieval Sheath are investigational devices and are not for sale in the US or outside the US.

Julia Pring, MD is recognized by Continental Who's Who

Retrieved on: 
Tuesday, September 20, 2022
American Academy, Degenerative disease, Infection, Alaska Native Medical Center, American Board of Commissioners for Foreign Missions, Trauma Center, University, MD, Bachelor of Science in Nursing, Tennis, Neoplasm, Medical degree, Texas Medical Association, Elective surgery, Health, Patient, Physician, ABOS, Walking, Stritch School of Medicine, Family, SAN, Orthopedic surgery, Bucknell University, Education, Mentorship, Continental, Dentistry, Lehigh Valley, Medicine

SAN ANTONIO, Sept. 20, 2022 /PRNewswire/ -- Julia Pring, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider and in acknowledgment of her outstanding accomplishments at South Texas Bone and Joint Institute.

Key Points: 
  • SAN ANTONIO, Sept. 20, 2022 /PRNewswire/ -- Julia Pring, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider and in acknowledgment of her outstanding accomplishments at South Texas Bone and Joint Institute.
  • To begin her college education, Dr. Pring completed a Bachelor of Science degree at Bucknell University in 2000.
  • Dr. Pring completed an Orthopedic Surgery residency at the University of New Mexico in Albuquerque.
  • In her free time, Dr. Pring enjoys hiking, walking, playing tennis, and spending time with her family, and her two giant schnauzers.

Amrish T. Patel, MD, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, August 16, 2022
Mentorship, Fracture, Wrist, Forearm, American Academy, Diagnosis, Chicago (franchise), Trauma, American Society for Surgery of the Hand, Society, Orthopedic surgery, Continental, Neoplasm, Patient, Human, Loyola University Medical Center, Degenerative disease, Infection, Birth, Elbow, Physician, University, Finger, Rice University, Stritch School of Medicine, Loyola University, Dentistry, Medicine, Hand, Medicine, MD

MARIETTA, Ga., Aug. 16, 2022 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Trusted Orthopedic Surgeon in the Medical field, acknowledging his professional excellence with Atlanta Hand Specialist.

Key Points: 
  • MARIETTA, Ga., Aug. 16, 2022 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Trusted Orthopedic Surgeon in the Medical field, acknowledging his professional excellence with Atlanta Hand Specialist.
  • He always takes the time to listen to patients and gives complete explanations of the diagnosis and treatment plans.
  • Dr. Patel has three years of experience in his current position and 14 years of picking up expertise in his field.
  • The doctor wishes to acknowledge his mentors: Daniel Mass, MD, and the owner of this practice, Viral Kumar Patel, MD.